Browse by People


Up a level
Export as [feed] RSS [feed] RSS 2.0 Short Author List
Number of items: 18.


Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ross, Paul J, Silcocks, Paul, Greenhalf, William, Faluyi, Olusola Olusesan, Ma, Yuk Ting, Wadsley, Jonathan, Rawcliffe, Charlotte Louise, Valle, Juan W and Neoptolemos, John P
(2018) ACELARATE: A phase III, open label, multicentre randomised clinical study comparing Acelarin (NUC-1031) with gemcitabine in patients with metastatic pancreatic carcinoma. .


Faluyi, Olusola O, Connor, Joanna L, Chatterjee, Madhuchanda, Ikin, Carl, Wong, Helen and Palmer, Daniel H ORCID: 0000-0002-7147-5703
(2017) Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre. BRITISH JOURNAL OF CANCER, 116 (4). 424 - 431.


Psarelli, Eftychia E ORCID: 0000-0002-3102-0288, Jackson, Richard, Neoptolemos, John P, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ghaneh, Paula, Halloran, Christopher M ORCID: 0000-0002-5471-4178 and Buechler, Markus W
(2017) Beyond ESPAC-4: better surgery and systemic therapy. LANCET, 389 (10078). 1517 - 1518.


Backen, Alison C, Lopes, Andre, Wasan, Harpreet, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Duggan, Marian, Cunningham, David, Anthoney, Alan, Corrie, Pippa G, Madhusudan, Srinivasan, Maraveyas, Anthony
et al (show 9 more authors) (2018) Circulating biomarkers during treatment in patients with advanced biliary tract cancer receiving cediranib in the UK ABC-03 trial. BRITISH JOURNAL OF CANCER, 119 (1). 27 - 35.


Neoptolemos, John P, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Ghaneh, Paula, Psarelli, Eftychia E ORCID: 0000-0002-3102-0288, Valle, Juan W, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Faluyi, Olusola, O'Reilly, Derek A, Cunningham, David, Wadsley, Jonathan
et al (show 25 more authors) (2017) Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial. LANCET, 389 (10073). 1011 - 1024.


Evans, Jonathan P ORCID: 0000-0001-7437-7669, Winiarski, Boleslaw K, Sutton, Paul A, Ressel, Lorenzo ORCID: 0000-0002-6614-1223, Duckworth, Carrie A, Pritchard, D Mark ORCID: 0000-0001-7971-3561, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Goldring, Christopher E and Kitteringham, Neil R
(2019) Development of an orthotopic syngeneic murine model of colorectal cancer for use in translational research. Laboratory animals. 23677219826165 - ?.


Hussain, Syed A, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Syn, Wing Kin, Sacco, Joseph J, Lloyd, Bryony, Jithesh, Puthen, Arrand, John R, Barton, Darren, Ansari, Jawaher, Sibson, David R
et al (show 1 more authors) (2013) Gene expression profiling in bladder cancer to identify potential therapeutic targets. JOURNAL OF CLINICAL ONCOLOGY, 31 (15).


Mahajan, Ujjwal Mukund, Langhoff, Eno, Goni, Elisabetta, Costello, Eithne, Greenhalf, William, Halloran, Christopher ORCID: 0000-0002-5471-4178, Ormanns, Steffen, Kruger, Stephan, Boeck, Stefan, Ribback, Silvia
et al (show 19 more authors) (2018) Immune Cell and Stromal Signature Associated With Progression-Free Survival of Patients With Resected Pancreatic Ductal Adenocarcinoma. GASTROENTEROLOGY, 155 (5). 1625 - +.


Middleton, Gary, Greenhalf, William, Costello, Eithne, Shaw, Victoria, Cox, Trevor, Ghaneh, Paula, Palmer, Daniel H ORCID: 0000-0002-7147-5703 and Neoptolemos, John P
(2016) Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma. BRITISH JOURNAL OF CANCER, 114 (5). 510 - 518.


Ghaneh, Paula, Kleeff, Jorg, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Raraty, Michael, Jackson, Richard, Melling, James, Jones, Owain, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Cox, Trevor F, Smith, Chloe J
et al (show 23 more authors) (2019) The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. ANNALS OF SURGERY, 269 (3). 520 - 529.


Quaranta, Valeria, Rainer, Carolyn, Nielsen, Sebastian R, Raymant, Meirion L, Ahmed, Muhammad S ORCID: 0000-0001-6163-8102, Engle, Dannielle D, Taylor, Arthur ORCID: 0000-0003-2028-6694, Murray, Trish, Campbell, Fiona, Palmer, Daniel H ORCID: 0000-0002-7147-5703
et al (show 3 more authors) (2018) Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer. CANCER RESEARCH, 78 (15). 4253 - 4269.


Evans, Jonathan P, Winiarski, Boleslaw K, Sutton, Paul A, Jones, Robert P, Ressel, Lorenzo ORCID: 0000-0002-6614-1223, Duckworth, Carrie A, Pritchard, D Mark, Lin, Zhi-Xiu, Fretwell, Vicky L, Tweedle, Elizabeth M
et al (show 6 more authors) (2018) The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer. Oncotarget, 9 (43). 27104 - 27116.


Jones, Robert P, Psarelli, Eftychia-Eirini ORCID: 0000-0002-3102-0288, Jackson, Richard, Ghaneh, Paula, Halloran, Christopher M ORCID: 0000-0002-5471-4178, Palmer, Daniel H, Campbell, Fiona, Valle, Juan W, Faluyi, Olusola, O'Reilly, Derek A
et al (show 31 more authors) (2019) Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma: A Secondary Analysis of the ESPAC-4 Randomized Adjuvant Chemotherapy Trial. JAMA surgery.


Meyer, Tim, Fox, Richard, Ma, Yuk Ting, Ross, Paul J, James, Martin W, Sturgess, Richard, Stubbs, Clive, Stocken, Deborah D, Wall, Lucy, Watkinson, Anthony
et al (show 8 more authors) (2017) Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2 (8). 565 - 575.


Ma, Yuk Ting, Leonard, Sarah M, Gordon, Naheema, Anderton, Jennifer, James, Claire, Huen, David, Woodman, Ciaran B and Palmer, Daniel H ORCID: 0000-0002-7147-5703
(2017) Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer. ONCOTARGET, 8 (38). 63635 - 63645.


Ma, Yuk Ting ORCID: 0000-0001-7830-6091, Leonard, Sarah M, Gordon, Naheema, Anderton, Jennifer, James, Claire, Huen, David, Woodman, Ciaran B and Palmer, Daniel H ORCID: 0000-0002-7147-5703
(2017) Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer. Oncotarget, 8 (38). 63635 - 63645.


Middleton, Gary, Palmer, Daniel H ORCID: 0000-0002-7147-5703, Greenhalf, William, Ghaneh, Paula, Jackson, Richard, Cox, Trevor, Evans, Anthony ORCID: 0000-0001-8547-1730, Shaw, Victoria E, Wadsley, Jonathan, Valle, Juan W
et al (show 14 more authors) (2017) Vandetanib plus gemcitabine versus placebo plus gemcitabine in locally advanced or metastatic pancreatic carcinoma (ViP): a prospective, randomised, double-blind, multicentre phase 2 trial. LANCET ONCOLOGY, 18 (4). 486 - 499.


Edeline, Julien, Blanc, Jean-Frederic, Johnson, Philip, Campillo-Gimenez, Boris, Ross, Paul, Ma, Yuk Ting, King, Judy, Hubner, Richard A, Sumpter, Kate, Darby, Suzanne
et al (show 8 more authors) (2016) A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular Carcinoma. LIVER INTERNATIONAL, 36 (12). 1821 - 1828.

This list was generated on Mon Nov 4 17:04:59 2019 GMT.